03-20-2017 08:43 PM CET - Health & Medicine

Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs

Press release from: ReportsWorldwide

ReportsWorldwide has announced the addition of a new report title Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs to its growing collection of premium market research reports.

GBI Research's latest report, ""Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs"", discusses global commercial trends and prospects for human medicines applied in the veterinary setting, also called crossover drugs.

This new report provides insights into Extra-label Drug Use (ELDU), its application in the veterinary setting and other guidelines and regulations followed by professionals in the animal health industry. Through a series of in-depth case studies this report provides insights into the rationale for the transition of several human drugs to the veterinary setting as well as disease overviews, competing treatments, manufacturer information, dosage forms, cost of therapy and other insightful marketing information. Our new study also identifies and explores important drivers and restraints of the crossover drugs market.

To Enquire about this Report please visit @ www.reportsworldwide.com/enquiry?report_id=8359

Scope of the Research Report

- What regulations need to be followed when prescribing human drugs off-label to pets and food-producing animals?

- What are the main factors driving the prescription of human medicines in animals?

- Marketed human drugs commonly used in companion animals

- What are the differences in indication between the human and veterinary setting?

- What are the dosage and side effects of those specific drugs in animals?

- Are there any existing and approved veterinary therapies for the same indication?

- Why is the human drug preferred over the approved animal drug?

- What are the key drivers and barriers that affect ELDU of human drugs in animals?

- What is currently restricting the crossover drugs market?

- What are the key animal health companies with prominent crossover drug portfolios?

- Explore recent financial performance, crossover drugs brands, and the number of species supported through their animal health product portfolio

- Identify emerging companies in the animal health market investigating and marketing crossover drugs

To view a detailed description and Table of Contents please visit: www.reportsworldwide.com/report/human-drugs-for-veterinar...

Reasons to buy

- Gain insightful analyses and understanding of the crossover drugs market: This report describes and assesses the key differences between the human and animal healthcare markets, areas of unmet need in the veterinary market and key factors responsible for ELDU in the veterinary setting.

- Assess high-profile marketed human products used for treating animals: Our new study provides analyses of the key human therapies that have the potential to be transitioned in the veterinary space.

- Identify the most important drivers and restraints of the crossover drugs market: This report provides insights regarding what is currently driving the prescription and application of human drugs in the veterinary setting as well as the current factors restraining further transition.

- Review the key and emerging companies that market crossover drugs and the business strategies being employed: This report assesses current tactics used by top veterinary pharmaceutical companies in manufacturing and marketing cross-over drugs. It also reviews the emerging companies that manufacture cross-over drugs for various indications.

- Assess future trends in the veterinary market: This report contain

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995

This release was published on openPR.
News-ID: 475240 • Views: 261
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.

You can edit or delete your press release here: